SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies shines on getting EU GMP certification for OSD facility in Himachal Pradesh

29 May 2026 Evaluate

Indoco Remedies is currently trading at Rs. 211.00, up by 7.25 points or 3.56% from its previous closing of Rs. 203.75 on the BSE.

The scrip opened at Rs. 216.00 and has touched a high and low of Rs. 220.20 and Rs. 208.55 respectively. So far 28700 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 348.10 on 17-Jul-2025 and a 52 week low of Rs. 163.70 on 30-Mar-2026.

Last one week high and low of the scrip stood at Rs. 270.00 and Rs. 191.00 respectively. The current market cap of the company is Rs. 1958.22 crore.

The promoters holding in the company stood at 58.86%, while Institutions and Non-Institutions held 19.09% and 22.04% respectively.

Indoco Remedies has received EU GMP certification from the German Health Authority (Berlin) for its Oral Solid Dosage (OSD) manufacturing facility (Plant III) located at Baddi, Himachal Pradesh. The inspection was carried out from April 22, 2026, to April 27, 2026.

This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

213.90 4.45 (2.12%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.35
Dr. Reddys Lab 1267.05
Cipla 1397.75
Zydus Lifesciences 1085.45
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×